Vistagen Therapeutics is doubling down on its lead social anxiety candidate, even after the asset failed a phase 3 trial last December. | Vistagen Therapeutics is doubling down on its lead social ...

Researchers discovered that R. inulinivorans plays an important role in muscle strength and could act as a probiotic candidate for nutraceutical interventions targeting age-related muscle-wasting ...